Liver fat content, non-alcoholic fatty liver disease, and ischaemic heart disease: Mendelian randomization and meta-analysis of 279 013 individuals

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Liver fat content, non-alcoholic fatty liver disease, and ischaemic heart disease : Mendelian randomization and meta-analysis of 279 013 individuals. / Lauridsen, Bo Kobberø; Stender, Stefan; Kristensen, Thomas Skårup; Kofoed, Klaus Fuglsang; Køber, Lars; Nordestgaard, Børge G.; Tybjærg-Hansen, Anne.

In: European Heart Journal, Vol. 39, No. 5, 2018, p. 385-393.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Lauridsen, BK, Stender, S, Kristensen, TS, Kofoed, KF, Køber, L, Nordestgaard, BG & Tybjærg-Hansen, A 2018, 'Liver fat content, non-alcoholic fatty liver disease, and ischaemic heart disease: Mendelian randomization and meta-analysis of 279 013 individuals', European Heart Journal, vol. 39, no. 5, pp. 385-393. https://doi.org/10.1093/eurheartj/ehx662

APA

Lauridsen, B. K., Stender, S., Kristensen, T. S., Kofoed, K. F., Køber, L., Nordestgaard, B. G., & Tybjærg-Hansen, A. (2018). Liver fat content, non-alcoholic fatty liver disease, and ischaemic heart disease: Mendelian randomization and meta-analysis of 279 013 individuals. European Heart Journal, 39(5), 385-393. https://doi.org/10.1093/eurheartj/ehx662

Vancouver

Lauridsen BK, Stender S, Kristensen TS, Kofoed KF, Køber L, Nordestgaard BG et al. Liver fat content, non-alcoholic fatty liver disease, and ischaemic heart disease: Mendelian randomization and meta-analysis of 279 013 individuals. European Heart Journal. 2018;39(5):385-393. https://doi.org/10.1093/eurheartj/ehx662

Author

Lauridsen, Bo Kobberø ; Stender, Stefan ; Kristensen, Thomas Skårup ; Kofoed, Klaus Fuglsang ; Køber, Lars ; Nordestgaard, Børge G. ; Tybjærg-Hansen, Anne. / Liver fat content, non-alcoholic fatty liver disease, and ischaemic heart disease : Mendelian randomization and meta-analysis of 279 013 individuals. In: European Heart Journal. 2018 ; Vol. 39, No. 5. pp. 385-393.

Bibtex

@article{65f4d4282b504193a1fb173bbc885e3f,
title = "Liver fat content, non-alcoholic fatty liver disease, and ischaemic heart disease: Mendelian randomization and meta-analysis of 279 013 individuals",
abstract = "Aims: In observational studies, non-alcoholic fatty liver disease (NAFLD) is associated with high risk of ischaemic heart disease (IHD). We tested the hypothesis that a high liver fat content or a diagnosis of NAFLD is a causal risk factor for IHD. Methods and results: In a cohort study of the Danish general population (n = 94708/IHD = 10 897), we first tested whether a high liver fat content or a diagnosis of NAFLD was associated observationally with IHD. Subsequently, using Mendelian randomization, we tested whether a genetic variant in the gene encoding the protein patatin-like phospholipase domain containing 3 protein (PNPLA3), I148M (rs738409), a strong and specific cause of high liver fat content and NAFLD, was causally associated with the risk of IHD. We found that the risk of IHD increased stepwise with increasing liver fat content (in quartiles) up to an odds ratio (OR) of 2.41 (1.28-4.51)(P-trend = 0.004). The corresponding OR for IHD in individuals with vs. without NAFLD was 1.65 (1.34-2.04)(P = 3 × 10 -6 ). PNPLA3 I148M was associated with a stepwise increase in liver fat content of up to 28{\%} in MM vs. II-homozygotes (P-trend = 0.0001) and with ORs of 2.03 (1.52-2.70) for NAFLD (P = 3x10 -7 ), 3.28 (2.37-4.54) for cirrhosis (P = 4 × 10 -12 ), and 0.95 (0.86-1.04) for IHD (P = 0.46). In agreement, in meta-analysis (N = 279013/IHD = 71 698), the OR for IHD was 0.98 (0.96-1.00) per M-allele vs. I-allele. The OR for IHD per M-allele higher genetically determined liver fat content was 0.98 (0.94-1.03) vs. an observational estimate of 1.05 (1.02-1.09)(P for comparison = 0.02). Conclusion: Despite confirming the known observational association of liver fat content and NAFLD with IHD, lifelong, genetically high liver fat content was not causally associated with risk of IHD. These results suggest that the observational association is due to confounding or reverse causation.",
keywords = "Cardiovascular disease, Causality, Epidemiology, Genetics, Liver disease",
author = "Lauridsen, {Bo Kobber{\o}} and Stefan Stender and Kristensen, {Thomas Sk{\aa}rup} and Kofoed, {Klaus Fuglsang} and Lars K{\o}ber and Nordestgaard, {B{\o}rge G.} and Anne Tybj{\ae}rg-Hansen",
year = "2018",
doi = "10.1093/eurheartj/ehx662",
language = "English",
volume = "39",
pages = "385--393",
journal = "European Heart Journal",
issn = "0195-668X",
publisher = "Oxford University Press",
number = "5",

}

RIS

TY - JOUR

T1 - Liver fat content, non-alcoholic fatty liver disease, and ischaemic heart disease

T2 - Mendelian randomization and meta-analysis of 279 013 individuals

AU - Lauridsen, Bo Kobberø

AU - Stender, Stefan

AU - Kristensen, Thomas Skårup

AU - Kofoed, Klaus Fuglsang

AU - Køber, Lars

AU - Nordestgaard, Børge G.

AU - Tybjærg-Hansen, Anne

PY - 2018

Y1 - 2018

N2 - Aims: In observational studies, non-alcoholic fatty liver disease (NAFLD) is associated with high risk of ischaemic heart disease (IHD). We tested the hypothesis that a high liver fat content or a diagnosis of NAFLD is a causal risk factor for IHD. Methods and results: In a cohort study of the Danish general population (n = 94708/IHD = 10 897), we first tested whether a high liver fat content or a diagnosis of NAFLD was associated observationally with IHD. Subsequently, using Mendelian randomization, we tested whether a genetic variant in the gene encoding the protein patatin-like phospholipase domain containing 3 protein (PNPLA3), I148M (rs738409), a strong and specific cause of high liver fat content and NAFLD, was causally associated with the risk of IHD. We found that the risk of IHD increased stepwise with increasing liver fat content (in quartiles) up to an odds ratio (OR) of 2.41 (1.28-4.51)(P-trend = 0.004). The corresponding OR for IHD in individuals with vs. without NAFLD was 1.65 (1.34-2.04)(P = 3 × 10 -6 ). PNPLA3 I148M was associated with a stepwise increase in liver fat content of up to 28% in MM vs. II-homozygotes (P-trend = 0.0001) and with ORs of 2.03 (1.52-2.70) for NAFLD (P = 3x10 -7 ), 3.28 (2.37-4.54) for cirrhosis (P = 4 × 10 -12 ), and 0.95 (0.86-1.04) for IHD (P = 0.46). In agreement, in meta-analysis (N = 279013/IHD = 71 698), the OR for IHD was 0.98 (0.96-1.00) per M-allele vs. I-allele. The OR for IHD per M-allele higher genetically determined liver fat content was 0.98 (0.94-1.03) vs. an observational estimate of 1.05 (1.02-1.09)(P for comparison = 0.02). Conclusion: Despite confirming the known observational association of liver fat content and NAFLD with IHD, lifelong, genetically high liver fat content was not causally associated with risk of IHD. These results suggest that the observational association is due to confounding or reverse causation.

AB - Aims: In observational studies, non-alcoholic fatty liver disease (NAFLD) is associated with high risk of ischaemic heart disease (IHD). We tested the hypothesis that a high liver fat content or a diagnosis of NAFLD is a causal risk factor for IHD. Methods and results: In a cohort study of the Danish general population (n = 94708/IHD = 10 897), we first tested whether a high liver fat content or a diagnosis of NAFLD was associated observationally with IHD. Subsequently, using Mendelian randomization, we tested whether a genetic variant in the gene encoding the protein patatin-like phospholipase domain containing 3 protein (PNPLA3), I148M (rs738409), a strong and specific cause of high liver fat content and NAFLD, was causally associated with the risk of IHD. We found that the risk of IHD increased stepwise with increasing liver fat content (in quartiles) up to an odds ratio (OR) of 2.41 (1.28-4.51)(P-trend = 0.004). The corresponding OR for IHD in individuals with vs. without NAFLD was 1.65 (1.34-2.04)(P = 3 × 10 -6 ). PNPLA3 I148M was associated with a stepwise increase in liver fat content of up to 28% in MM vs. II-homozygotes (P-trend = 0.0001) and with ORs of 2.03 (1.52-2.70) for NAFLD (P = 3x10 -7 ), 3.28 (2.37-4.54) for cirrhosis (P = 4 × 10 -12 ), and 0.95 (0.86-1.04) for IHD (P = 0.46). In agreement, in meta-analysis (N = 279013/IHD = 71 698), the OR for IHD was 0.98 (0.96-1.00) per M-allele vs. I-allele. The OR for IHD per M-allele higher genetically determined liver fat content was 0.98 (0.94-1.03) vs. an observational estimate of 1.05 (1.02-1.09)(P for comparison = 0.02). Conclusion: Despite confirming the known observational association of liver fat content and NAFLD with IHD, lifelong, genetically high liver fat content was not causally associated with risk of IHD. These results suggest that the observational association is due to confounding or reverse causation.

KW - Cardiovascular disease

KW - Causality

KW - Epidemiology

KW - Genetics

KW - Liver disease

U2 - 10.1093/eurheartj/ehx662

DO - 10.1093/eurheartj/ehx662

M3 - Journal article

C2 - 29228164

AN - SCOPUS:85044116085

VL - 39

SP - 385

EP - 393

JO - European Heart Journal

JF - European Heart Journal

SN - 0195-668X

IS - 5

ER -

ID: 214339664